SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 131 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $1,210,000 | -9.2% | 123,428 | 0.0% | 0.30% | -4.5% |
Q4 2016 | $1,333,000 | +10.0% | 123,428 | +4.4% | 0.31% | +12.1% |
Q3 2016 | $1,212,000 | -5.3% | 118,228 | +20.6% | 0.28% | -10.3% |
Q2 2016 | $1,280,000 | +65.6% | 98,006 | +39.5% | 0.31% | +48.6% |
Q1 2016 | $773,000 | +12.0% | 70,238 | -6.4% | 0.21% | +21.4% |
Q4 2015 | $690,000 | +16.6% | 75,038 | +0.9% | 0.17% | +9.5% |
Q3 2015 | $592,000 | -9.9% | 74,338 | +0.0% | 0.16% | -31.6% |
Q2 2015 | $657,000 | +3.6% | 74,336 | +3.9% | 0.23% | -6.9% |
Q1 2015 | $634,000 | +1.1% | 71,563 | -0.0% | 0.25% | -3.5% |
Q4 2014 | $627,000 | +27.2% | 71,569 | 0.0% | 0.26% | +32.5% |
Q3 2014 | $493,000 | +33.2% | 71,569 | -4.0% | 0.19% | +1.6% |
Q2 2013 | $370,000 | – | 74,545 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,663,281 | $16,300,000 | 9.19% |
Nantahala Capital Management | 1,891,328 | $18,535,000 | 2.06% |
Nine Chapters Capital Management LLC | 40,700 | $399,000 | 0.54% |
MENTA CAPITAL LLC | 396,336 | $3,884,000 | 0.38% |
Sapphire Star Partners LP | 30,439 | $298,000 | 0.34% |
TFS CAPITAL LLC | 95,432 | $935,000 | 0.30% |
Ativo Capital Management LLC | 123,428 | $1,210,000 | 0.30% |
GLG Partners LP | 363,188 | $3,559,000 | 0.17% |
GSA CAPITAL PARTNERS LLP | 240,013 | $2,352,000 | 0.13% |
Bowling Portfolio Management LLC | 68,473 | $671,000 | 0.11% |